Systematic classification of CDR‐L3 in antibodies: Implications of the light chain subtypes and the VL–VH interface

Antibody modeling is widely used for the analysis of antibody–antigen interactions and for the design of potent antibody drugs. The antibody combining site is composed of six complementarity determining regions (CDRs). The CDRs, except for CDR‐H3, which is the most diverse CDR, form limited numbers of canonical structures, which can be identified from the amino acid sequences. A method to classify the CDR‐H3 structure from its amino acid sequence was previously proposed. However, since those CDR structures were classified, many more antibody crystal structures have been determined. We performed systematic analyses of the CDR‐L3 structures and found novel canonical structures, and we also classified a previously identified canonical structure into two subtypes. In addition, two differently defined canonical structures in the κ and λ subtypes were classified into the same canonical structure. We also identified a key residue in CDR‐L3, which determines the conformation of CDR‐H3. Several analyses of CDR‐L3 loops longer than nine residues were performed. These new findings should be useful for structural modeling and are eventually expected to accelerate the design of antibody drugs. Proteins 2009. © 2008 Wiley‐Liss, Inc.

[1]  Oleg V. Koliasnikov,et al.  Antibody Cdr H3 Modeling Rules: Extension for the Case of Absence of Arg H94 and Asp H101 , 2006, J. Bioinform. Comput. Biol..

[2]  Haruki Nakamura,et al.  H3‐rules: identification of CDR‐H3 structures in antibodies , 1999, FEBS letters.

[3]  Arthur M. Lesk,et al.  Introduction to protein architecture : the structural biologyof proteins , 2001 .

[4]  M. Sternberg,et al.  Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. , 1998, Journal of molecular biology.

[5]  Lutz Riechmann,et al.  Reshaping human antibodies for therapy , 1988, Nature.

[6]  A Tramontano,et al.  Antibody modeling: implications for engineering and design. , 2000, Methods.

[7]  Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Erikson,et al.  Assignment of the genes for human lambda immunoglobulin chains to chromosome 22. , 1981, Nature.

[9]  P. T. Jones,et al.  Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.

[10]  A. Lesk,et al.  Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.

[11]  B. L. Sibanda,et al.  β-Hairpin families in globular proteins , 1985, Nature.

[12]  B. L. Sibanda,et al.  Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. , 1989, Journal of molecular biology.

[13]  A. Lesk,et al.  The structural repertoire of the human V kappa domain. , 1995, The EMBO journal.

[14]  J. Thornton,et al.  A revised set of potentials for β‐turn formation in proteins , 1994 .

[15]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[16]  A G Murzin,et al.  SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.

[17]  J. Bravo,et al.  Conformation of the hypervariable region L3 without the key proline residue , 1996, Protein science : a publication of the Protein Society.

[18]  M. Ferguson-Smith,et al.  Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Papavasiliou,et al.  V(D)J Recombination and the Evolution of the Adaptive Immune System , 2003, PLoS biology.

[20]  S. Tonegawa,et al.  Somatic generation of antibody diversity. , 1976, Nature.

[21]  Haruki Nakamura,et al.  Structural classification of CDR‐H3 revisited: A lesson in antibody modeling , 2008, Proteins.

[22]  B. L. Sibanda,et al.  Beta-hairpin families in globular proteins. , 1985, Nature.

[23]  Haruki Nakamura,et al.  Structural classification of CDR‐H3 in antibodies , 1996, FEBS letters.

[24]  A. Lesk,et al.  Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.

[25]  A T Brünger,et al.  2.9 A resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten. , 1991, Journal of molecular biology.

[26]  C. Chothia,et al.  Domain association in immunoglobulin molecules. The packing of variable domains. , 1985, Journal of molecular biology.

[27]  A. Denman.  Cellular and Molecular Immunology , 1992 .

[28]  A Tramontano,et al.  Conformations of the third hypervariable region in the VH domain of immunoglobulins. , 1998, Journal of molecular biology.

[29]  Benny K. C. Lo,et al.  Antibody humanization by CDR grafting. , 2004, Methods in molecular biology.

[30]  C. Milstein,et al.  Reshaping human antibodies: grafting an antilysozyme activity. , 1988, Science.

[31]  A. Murzin,et al.  The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A R Rees,et al.  WAM: an improved algorithm for modelling antibodies on the WEB. , 2000, Protein engineering.

[33]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[34]  M. Lascombe,et al.  Three-dimensional structure of antibodies. , 1988, Annual review of immunology.

[35]  Enrique Vargas-Madrazo,et al.  Modifications to canonical structure sequence patterns: Analysis for L1 and L3 , 2002, Proteins.

[36]  Jeffrey J. Gray,et al.  Modeling the structure of mAb 14B7 bound to the anthrax protective antigen , 2007, Proteins.

[37]  Bruce Tidor,et al.  Computational design of antibody-affinity improvement beyond in vivo maturation , 2007, Nature Biotechnology.

[38]  Andrew C. R. Martin,et al.  Accessing the Kabat antibody sequence database by computer , 1996, Proteins.